US Patent 12071482 Compositions and methods related to engineered Fc constructs

Is a

Patent

Patent attributes

Patent Applicant

Momenta Pharmaceuticals

Current Assignee

Momenta Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

120714820

Patent Inventor Names

Laura Rutitzky0

Leona E. Ling0

James Meador, III0

James S. Huston0

Carlos J. Bosques0

Jonathan C. Lansing0

Daniel Ortiz0

Date of Patent

August 27, 2024

Patent Application Number

174078140

Date Filed

August 20, 2021

Patent Citations

‌

US Patent 8680237 Immunoglobulin constant region FC receptor binding agents

‌

US Patent 9238080 Bi-specific fusion proteins

‌

US Patent 10239944 Compositions and methods related to engineered Fc constructs

‌

US Patent 11124573 Compositions and methods related to engineered Fc constructs

‌

US Patent 11155640 Compositions and methods related to engineered Fc constructs

‌

US Patent 11623964 Compositions and methods related to engineered Fc constructs

‌

US Patent 11220531 Engineered Fc constructs

‌

US Patent 7183076 Method for making multispecific antibodies having heteromultimeric and common components

...

Patent Primary Examiner

‌

Phuong Huynh

Patent abstract

The present invention relates to compositions and methods of engineered IgG Fc constructs, wherein said Fc constructs include one or more Fc domains.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 12071482 Compositions and methods related to engineered Fc constructs

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 12071482 Compositions and methods related to engineered Fc constructs